Ocular Therapeutix OCUL Business Segments — Cost of Goods Sold

Similar metrics at other companies

ACLSSingle Reportable — Cost of Goods Sold

$118.38M+14.0%

IOVASingle Reportable — Cost Of Goods And Service Excluding Depreciation Depletion And Amortization

$38.83M-0.4%

AAPReportable — Cost of Goods Sold

$1.43B-2.7%

APLEReportable — Cost of Goods Sold

$206.94M+3.5%

MMSISingle Reportable — Cost Of Goods And Service Excluding Depreciation Depletion And Amortization

$147.02M+3.0%

PLUSProduct Reporting Unit — Cost of Goods Sold

$381.43M+24.1%

Questions, answered.

What is Ocular Therapeutix's business segments — cost of goods sold?

Ocular Therapeutix (OCUL) reported business segments — cost of goods sold of $1.33M in Q1 2026.

How has Ocular Therapeutix's business segments — cost of goods sold changed year-over-year?

Ocular Therapeutix's business segments — cost of goods sold increased by 5.3% year-over-year, from $1.26M to $1.33M.

What is the long-term trend for Ocular Therapeutix's business segments — cost of goods sold?

Over 3 years (2022 to 2025), Ocular Therapeutix's business segments — cost of goods sold has grown at a 13.1% compound annual growth rate (CAGR), from $4.54M to $6.57M.

What does business segments — cost of goods sold mean?

This represents the direct costs attributable to the production and delivery of the company's ophthalmic products and services. Monitoring this metric helps assess the efficiency of the manufacturing process and the direct margin impact of product sales.